XOMA NASDAQ Week ended 17 Jul 2026

Weekly Investor Report

XOMA Royalty Corporation · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 40.17 USD
-9.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 17.6% above the Trend Line and sits at 78.0% of its 52-week range. The latest completed week returned -9.2%, after a -4.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 10d.

Setup score 64 out of 100
Latest Close 40.17 USD 17 Jul 2026
1W Return -9.2% latest completed week
4W Return -4.1% short-term follow-through
12W Return 6.0% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 4.3x vs 13-week average
What is working
  • The trend backdrop is active with a 12-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 5 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -9.2% Latest completed week; four-week move -4.1%. Indicator stack 75/54 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 56/100 59 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.6% above the Trend Line and sits at 78.0% of its 52-week range. The latest completed week returned -9.2%, after a -4.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 4.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
23 Jan 30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9012-week average 0.74

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.90Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers

No recent accumulation markers. 5 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.1% over four weeks, 6.0% over 12 weeks, and 56.5% over one year. The current trend has remained active for 12 consecutive weeks.

Performance by holding period

1W-9.2%
4W-4.1%
12W6.0%
26W52.3%
52W56.5%
Active trend streak12 weeks
Active weeks in one year32
Trend breadth61.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.49Latest activity-pressure read.
Pressure change-56.1%Four-week change in activity pressure.
Leadership8.95Latest relative-leadership reading.
RS change4.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 85% Model confidence 81%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength12/100Blend of value, momentum, and quality. Underlying universe rank 89; rank 1 is best.
Value4/100Relative valuation strength. Underlying universe rank 97; rank 1 is best.
Quality22/100Profitability and accounting quality. Underlying universe rank 79; rank 1 is best.
Momentum88/100Medium-term price momentum. Underlying universe rank 13; rank 1 is best.
Growth75/100Revenue and earnings growth. Underlying universe rank 26; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
21.0x
Price divided by trailing earnings.
Price / sales
92.8x
Market value relative to trailing revenue.
EV / EBITDA
14.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
65.0%
Operating profit retained from revenue.
Free-cash-flow margin
-182.0%
Free cash flow generated from revenue.
Return on invested capital
2.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.8%
Cash dividends relative to market value.
Buyback yield
1.6%
Net share repurchases relative to market value.
Shareholder yield
2.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 59 relevant articles.

18 positive · 36 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-11.2%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+11.4%Week of 10 Apr.
Worst week-9.2%Week of 17 Jul.
Latest week-9.2%Week of 17 Jul.

Shape of recent returns

Strong gains7
Modest gains10
Flat weeks0
Modest losses7
Sharp losses2
Recent vol4.0%13-week weekly-return volatility.
Base vol6.2%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape66/100

Trend, activity pressure, participation, and risk combine to a 66/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.90; 5 reversal markers Factors28/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 26; Small Cap Core rank 93 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment56/100

Weighted news tone is neutral across 59 relevant articles.

XOMA Royalty Corp (XOMA) Dividends & Stock Splits: Historical Payouts and Event Timeline Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
17 Jul 202640.17 USD-9.2%34.17 USD26.70 USD0.498.956.7MOn
10 Jul 202644.22 USD2.8%33.68 USD26.55 USD0.7215.441.3MOn
3 Jul 202643.00 USD2.0%33.04 USD26.37 USD0.8714.79830.4KOn
26 Jun 202642.15 USD0.6%32.61 USD26.20 USD1.0213.97966.5KOn
19 Jun 202641.89 USD0.2%32.27 USD26.05 USD1.138.55410.9KOn
12 Jun 202641.79 USD-0.7%31.94 USD25.90 USD1.2011.62600.1KOn
5 Jun 202642.09 USD0.9%31.63 USD25.75 USD1.2315.56442.0KOn
29 May 202641.71 USD0.1%31.33 USD25.59 USD1.279.84440.1KOn
22 May 202641.65 USD-0.2%31.04 USD25.43 USD1.4013.22506.3KOn
15 May 202641.75 USD-0.3%30.83 USD25.28 USD1.3715.26542.8KOn
8 May 202641.89 USD1.2%30.59 USD25.14 USD1.3615.58918.0KOn
1 May 202641.38 USD9.2%30.41 USD24.99 USD1.3120.876.0MOn
24 Apr 202637.90 USD-4.6%30.35 USD24.84 USD1.1112.91519.2KOff
17 Apr 202639.71 USD8.1%30.31 USD24.72 USD0.9921.17825.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.